The effectiveness of chitosan-mediated silencing of PDGF-B and PDGFR-β within the mesangial proliferative glomerulonephritis remedy.
Nanoparticle-based therapeutics are most well-liked for causes reminiscent of growing therapeutic efficacy and decreasing poisonous results brought on by excessive doses. The distribution of nanoparticles to the kidney is a big benefit in siRNA supply.
The purpose of this research was to research the efficacy of chitosan/siRNA nanoplexes in silencing of PDGF-B and PDGFR-β genes in kidney and to lower mesangial cell proliferation and matrix accumulation in MsPGN mannequin induced by anti-Thy-1.1 antibody.
Anti-PDGF alpha antibody |

human anti-human PDGF-BB mAb(B32) |
|||
E4A09D45-B32 | EnoGene | 100ug | EUR 595 |
human anti-human PDGF-BB mAb(B45) |
|||
E4A09D45-B45 | EnoGene | 100ug | EUR 595 |
human anti-human PDGF-BB mAb(B48) |
|||
E4A09D45-B48 | EnoGene | 100ug | EUR 595 |
human anti-human PDGF-BB mAb(C57) |
|||
E4A09D45-C57 | EnoGene | 100ug | EUR 595 |
Human PDGF-B |
|||
vAP-0004 | Angio Proteomie | 1ml | EUR 1620 |
Human PDGF-BB |
|||
MBS691616-0002mg | MyBiosource | 0.002mg | EUR 225 |
Human PDGF-BB |
|||
MBS691616-5x0002mg | MyBiosource | 5x0.002mg | EUR 725 |
Human PDGF-AB |
|||
MBS691640-002mg | MyBiosource | 0.02mg | EUR 360 |
Human PDGF-AB |
|||
MBS691640-5x002mg | MyBiosource | 5x0.02mg | EUR 1325 |
Human PDGF-AA |
|||
MBS691878-0005mg | MyBiosource | 0.005mg | EUR 245 |
Human PDGF-AA |
|||
MBS691878-5x0005mg | MyBiosource | 5x0.005mg | EUR 800 |
Human PDGF-AB |
|||
MBS691944-0005mg | MyBiosource | 0.005mg | EUR 245 |
Human PDGF-AB |
|||
MBS691944-5x0005mg | MyBiosource | 5x0.005mg | EUR 800 |
Human PDGF-AA |
|||
MBS691946-002mg | MyBiosource | 0.02mg | EUR 360 |
Human PDGF-AA |
|||
MBS691946-5x002mg | MyBiosource | 5x0.02mg | EUR 1325 |
Human PDGF-AA |
|||
MBS691952-0002mg | MyBiosource | 0.002mg | EUR 225 |
Human PDGF-AA |
|||
MBS691952-5x0002mg | MyBiosource | 5x0.002mg | EUR 725 |
Human PDGF-AB |
|||
MBS691978-0002mg | MyBiosource | 0.002mg | EUR 225 |
Human PDGF-AB |
|||
MBS691978-5x0002mg | MyBiosource | 5x0.002mg | EUR 725 |
Human PDGF-BB |
|||
MBS692013-0005mg | MyBiosource | 0.005mg | EUR 245 |
Human PDGF-BB |
|||
MBS692013-5x0005mg | MyBiosource | 5x0.005mg | EUR 800 |
Human PDGF-CC |
|||
MBS692065-0005mg | MyBiosource | 0.005mg | EUR 300 |
Human PDGF-CC |
|||
MBS692065-002mg | MyBiosource | 0.02mg | EUR 450 |
Human PDGF-CC |
|||
MBS692065-5x002mg | MyBiosource | 5x0.02mg | EUR 1725 |
Human PDGF-BB |
|||
MBS692079-002mg | MyBiosource | 0.02mg | EUR 360 |
Human PDGF-BB |
|||
MBS692079-5x002mg | MyBiosource | 5x0.02mg | EUR 1325 |
PDGF - A Human |
|||
PR27059 | Neuromics | 5 ug | EUR 97.2 |
PDGF - A Human |
|||
PR27059-B | Neuromics | each | EUR 184.5 |
PDGF - B Human |
|||
PR27060 | Neuromics | 5 ug | EUR 97.2 |
PDGF - B Human |
|||
PR27060-B | Neuromics | each | EUR 184.5 |
PDGF - AA Human |
|||
PR27061 | Neuromics | 2 ug | EUR 97.2 |
PDGF - AA Human |
|||
PR27061-B | Neuromics | each | EUR 184.5 |
PDGF - AB Human |
|||
PR27062 | Neuromics | 2 ug | EUR 97.2 |
PDGF - AB Human |
|||
PR27062-B | Neuromics | each | EUR 184.5 |
PDGF, CF Human |
|||
PR15024CF | Neuromics | 5 ug | EUR 1743.6 |
Human PDGF receptor |
|||
E01A7143 | BlueGene | 96T | EUR 700 |
Description: ELISA |
Human PDGF receptor |
|||
E01P0755-48wellsplate | BlueGene | 48 wells plate | EUR 280 |
Human PDGF receptor |
|||
E01P0755-96wellsplate | BlueGene | 96 wells plate | EUR 405 |
PDGF-BB, Human |
|||
HY-P7055 | MedChemExpress | 10ug | EUR 321.6 |
PDGF-BB, human |
|||
RC216-21 | Bio Basic | 2ug | EUR 125.26 |
Anti-Human PDGF-A Antibody |
|||
102-P77 | ReliaTech | 100 µg | EUR 245.7 |
Description: Platelet-derived growth factor (PDGF) was discovered as a major mitogenic factor present in serum but absent from plasma. It was found to be secreted from the α-granules of platelets activated during the coagulation of blood to form serum. Subsequent studies have demonstrated that PDGF is not one molecule but three, each a dimeric combination of two distinct but structurally related peptide chains designated A and B. The dimeric isoforms PDGFAA, AB and BB are differentially expressed in various cell types and their effects are mediated through two distinct receptors, termed α and β. Differences exist in isoform binding to each receptor. In general, PDGF isoforms are potent mitogens for connective tissue cells, including dermal fibroblasts, glial cells, arterial smooth muscle cells and some epithelial and endothelial cells. In addition to its activity as a mitogen, PDGF is chemotactic for fibroblasts, smooth muscle cells, neutrophils and mononuclear cells. Other reported activities for PDGF include stimulation of granule release by neutrophils and monocytes, facilitation of steroid synthesis by Leydig cells, stimulation of neutrophil phagocytosis, inhibition of natural killer (NK) cell activity, stimulation of collagen synthesis, modulation of thrombospondin expression and secretion, stimulation of collagenase activity and secretion, induction of contraction of rat aorta strips in vitro, and transient induction of T cell IL2 secretion accompanied by a downregulation of IL4 and IFNγ production, temporary effects that may allow clonal expansion of antigen-activated B and T helper lymphocytes prior to differentiation. PDGF also appears to be ubiquitous in neurons throughout the CNS, where it is suggested to play an important role in neuron survival and regeneration, and in mediation of glial cell proliferation and differentiation. |
Anti-Human PDGF-A Antibody |
|||
101-M44 | ReliaTech | 100 µg | EUR 399 |
Description: Platelet-derived growth factor (PDGF) was discovered as a major mitogenic factor present in serum but absent from plasma. It was found to be secreted from the α-granules of platelets activated during the coagulation of blood to form serum. Subsequent studies have demonstrated that PDGF is not one molecule but three, each a dimeric combination of two distinct but structurally related peptide chains designated A and B. The dimeric isoforms PDGFAA, AB and BB are differentially expressed in various cell types and their effects are mediated through two distinct receptors, termed α and β. Differences exist in isoform binding to each receptor. In general, PDGF isoforms are potent mitogens for connective tissue cells, including dermal fibroblasts, glial cells, arterial smooth muscle cells and some epithelial and endothelial cells. In addition to its activity as a mitogen, PDGF is chemotactic for fibroblasts, smooth muscle cells, neutrophils and mononuclear cells. Other reported activities for PDGF include stimulation of granule release by neutrophils and monocytes, facilitation of steroid synthesis by Leydig cells, stimulation of neutrophil phagocytosis, inhibition of natural killer (NK) cell activity, stimulation of collagen synthesis, modulation of thrombospondin expression and secretion, stimulation of collagenase activity and secretion, induction of contraction of rat aorta strips in vitro, and transient induction of T cell IL2 secretion accompanied by a downregulation of IL4 and IFNγ production, temporary effects that may allow clonal expansion of antigen-activated B and T helper lymphocytes prior to differentiation. PDGF also appears to be ubiquitous in neurons throughout the CNS, where it is suggested to play an important role in neuron survival and regeneration, and in mediation of glial cell proliferation and differentiation. |
Anti-Human PDGF-B Antibody |
|||
101-M45 | ReliaTech | 100 µg | EUR 399 |
Description: PDGFs are disulfide-linked dimers consisting of two 12.0-13.5 kDa polypeptide chains, designated PDGF-A and PDGF-B chains. The three naturally occurring PDGFs; PDGF-AA, PDGF-BB and PDGF-AB, are potent mitogens for a variety of cell types including smooth muscle cells, connective tissue cells, bone and cartilage cells, and some blood cells. The PDGFs are stored in platelet α-granules and are released upon platelet activation. The PDGFs are involved in a number of biological processes, including hyperplasia, chemotaxis, embryonic neuron development, and respiratory tubule epithelial cell development. Two distinct signaling receptors used by PDGFs have been identified and named PDGFR-α and PDGFR-β. PDGFR-α is high-affinity receptor for each of the three PDGF forms. On the other hand, PDGFR-β interacts with only PDGF-BB and PDGF-AB. Recombinant human PDGF-BB is a 24.3 kDa disulfide-linked homodimer of two B chains (218 total amino acids). |
Anti-Human PDGF-A Antibody |
|||
101-M821 | ReliaTech | 100 µg | EUR 399 |
Description: Platelet-derived growth factor (PDGF) was discovered as a major mitogenic factor present in serum but absent from plasma. It was found to be secreted from the α-granules of platelets activated during the coagulation of blood to form serum. Subsequent studies have demonstrated that PDGF is not one molecule but three, each a dimeric combination of two distinct but structurally related peptide chains designated A and B. The dimeric isoforms PDGFAA, AB and BB are differentially expressed in various cell types and their effects are mediated through two distinct receptors, termed α and β. Differences exist in isoform binding to each receptor. In general, PDGF isoforms are potent mitogens for connective tissue cells, including dermal fibroblasts, glial cells, arterial smooth muscle cells and some epithelial and endothelial cells. In addition to its activity as a mitogen, PDGF is chemotactic for fibroblasts, smooth muscle cells, neutrophils and mononuclear cells. Other reported activities for PDGF include stimulation of granule release by neutrophils and monocytes, facilitation of steroid synthesis by Leydig cells, stimulation of neutrophil phagocytosis, inhibition of natural killer (NK) cell activity, stimulation of collagen synthesis, modulation of thrombospondin expression and secretion, stimulation of collagenase activity and secretion, induction of contraction of rat aorta strips in vitro, and transient induction of T cell IL2 secretion accompanied by a downregulation of IL4 and IFNγ production, temporary effects that may allow clonal expansion of antigen-activated B and T helper lymphocytes prior to differentiation. PDGF also appears to be ubiquitous in neurons throughout the CNS, where it is suggested to play an important role in neuron survival and regeneration, and in mediation of glial cell proliferation and differentiation. |
Anti-Human PDGF-B Antibody |
|||
101-M822 | ReliaTech | 100 µg | EUR 399 |
Description: PDGFs are disulfide-linked dimers consisting of two 12.0-13.5 kDa polypeptide chains, designated PDGF-A and PDGF-B chains. The three naturally occurring PDGFs; PDGF-AA, PDGF-BB and PDGF-AB, are potent mitogens for a variety of cell types including smooth muscle cells, connective tissue cells, bone and cartilage cells, and some blood cells. The PDGFs are stored in platelet α-granules and are released upon platelet activation. The PDGFs are involved in a number of biological processes, including hyperplasia, chemotaxis, embryonic neuron development, and respiratory tubule epithelial cell development. Two distinct signaling receptors used by PDGFs have been identified and named PDGFR-α and PDGFR-β. PDGFR-α is high-affinity receptor for each of the three PDGF forms. On the other hand, PDGFR-β interacts with only PDGF-BB and PDGF-AB. Recombinant human PDGF-BB is a 24.3 kDa disulfide-linked homodimer of two B chains (218 total amino acids). |
Anti-Human PDGF-C Antibody |
|||
101-M823 | ReliaTech | 100 µg | EUR 399 |
Description: Mouse platelet-derived growth factor C ( PDGF-C ) is one of the four member of the PDGF family of growth factors which are known mitogens and survival factors for cells of mesenchymal origin. They form four disulfide-linked homodimers ( PDGF-AA, -BB, -CC, and –DD ) and one heterodimer ( PDGF-AB ). PDGF-C has a unique two-domain structure consisting of an N-terminal CUB and a conserved C-terminal growth factor domain that are separated by a hinge region. PDGF-CC only binds to PDGF Rα with high affinity, activates the homodimerization of PDGF Rαβ, and induces the signal pathways, such as profibrotic pathways in hepatic fibrosis. PDGF-CC is involved in a variety of processes including angiogensis, morphogenesis and cardiovascular development, as well as the tumorigenesis. Meanwhile, recent studies have shown that the serine protease tissue plasminogen activator (tPA) used for treatment of acute stroke mediates the activation PDGF-CC, which suggests potential new strategies for cardiovascular and stroke treatment. |
Anti-Human PDGF-B Antibody |
|||
MBS4158493-01mg | MyBiosource | 0.1mg | EUR 920 |
Anti-Human PDGF-B Antibody |
|||
MBS4158493-5x01mg | MyBiosource | 5x0.1mg | EUR 3880 |
Anti-Human PDGF-BB Antibody |
|||
102-P78 | ReliaTech | 100 µg | EUR 245.7 |
Description: PDGFs are disulfide-linked dimers consisting of two 12.0-13.5 kDa polypeptide chains, designated PDGF-A and PDGF-B chains. The three naturally occurring PDGFs; PDGF-AA, PDGF-BB and PDGF-AB, are potent mitogens for a variety of cell types including smooth muscle cells, connective tissue cells, bone and cartilage cells, and some blood cells. The PDGFs are stored in platelet α-granules and are released upon platelet activation. The PDGFs are involved in a number of biological processes, including hyperplasia, chemotaxis, embryonic neuron development, and respiratory tubule epithelial cell development. Two distinct signaling receptors used by PDGFs have been identified and named PDGFR-α and PDGFR-β. PDGFR-α is high-affinity receptor for each of the three PDGF forms. On the other hand, PDGFR-β interacts with only PDGF-BB and PDGF-AB. Recombinant human PDGF-BB is a 24.3 kDa disulfide-linked homodimer of two B chains (218 total amino acids). |
Anti-Human PDGF-AA Antibody |
|||
MBS4158492-01mg | MyBiosource | 0.1mg | EUR 920 |
Anti-Human PDGF-AA Antibody |
|||
MBS4158492-5x01mg | MyBiosource | 5x0.1mg | EUR 3880 |
Human PDGF ELISA Kit |
|||
EHP0040 | Abclonal | 96Tests | EUR 625.2 |
rec PDGF BB (human) |
|||
4031083.0002 | Bachem | 2 µg | EUR 102.27 |
rec PDGF BB (human) |
|||
4031083.001 | Bachem | 10 µg | EUR 271.85 |
rec PDGF BB (human) |
|||
H-7530.0002 | Bachem | 2.0µg | EUR 194.4 |
rec PDGF BB (human) |
|||
H-7530.0010 | Bachem | 10.0µg | EUR 457.2 |
rec PDGF AA (human) |
|||
H-7640.0002 | Bachem | 2.0µg | EUR 194.4 |
rec PDGF AA (human) |
|||
H-7640.0010 | Bachem | 10.0µg | EUR 457.2 |
Human PDGF-BB Protein |
|||
abx060208-100g | Abbexa | 100 µg | Ask for price |
Human PDGF-BB Protein |
|||
abx060208-100ug | Abbexa | 100 ug | EUR 627.6 |
Human PDGF-BB Protein |
|||
abx060208-10g | Abbexa | 10 µg | EUR 243.75 |
Human PDGF-BB Protein |
|||
abx060208-50g | Abbexa | 50 µg | EUR 437.5 |
Human PDGF-BB Protein |
|||
abx060258-100ug | Abbexa | 100 ug | EUR 627.6 |
Human PDGF-αR ELISA Kit |
|||
EHP0039 | Abclonal | 96Tests | EUR 625.2 |
PDGF ELISA KIT|Human |
|||
EF007049 | Lifescience Market | 96 Tests | EUR 826.8 |
Recombinant Human pdgf-A |
|||
MBS7614788-005mg | MyBiosource | 0.05mg | EUR 405 |
Recombinant Human pdgf-A |
|||
MBS7614788-02mg | MyBiosource | 0.2mg | EUR 760 |
Recombinant Human pdgf-A |
|||
MBS7614788-1mg | MyBiosource | 1mg | EUR 2175 |
Recombinant Human pdgf-A |
|||
MBS7614788-5x1mg | MyBiosource | 5x1mg | EUR 8410 |
Recombinant Human PDGF-BB |
|||
EPT197 | ELK Biotech | 10ug | EUR 139.5 |
Description: Recombinant Human Platelet-Derived Growth Factor BB is produced by our E.coli expression system and the target gene encoding Ser82-Thr190 is expressed. |
recombinant human PDGF-BB |
|||
E4A10C38 | EnoGene | 100ug | EUR 595 |
Recombinant Human PDGF-AA |
|||
HEGFP-0508 | Cyagen | 10ug | Ask for price |
Recombinant Human PDGF-BB |
|||
HEGFP-1601 | Cyagen | 10ug | Ask for price |
Recombinant Human PDGF-AA |
|||
P1147-.01 | ApexBio | 10ug | EUR 272.8 |
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant Human PDGF-AA |
|||
P1147-.1 | ApexBio | 100ug | EUR 1171.2 |
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant Human PDGF-AA |
|||
P1147-.5 | ApexBio | 500ug | EUR 2627.2 |
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant Human PDGF-BB |
|||
SJA04-01 | Amyotop | 10µg/vial | EUR 307.2 |
PDGF-CC, human recombinant |
|||
7183-10 | Biovision | each | EUR 248.4 |
PDGF-CC, human recombinant |
|||
7183-50 | Biovision | each | EUR 810 |
PDGF-AA, human recombinant |
|||
4482-10 | Biovision | each | EUR 398.4 |
PDGF-AA, human recombinant |
|||
4482-1000 | Biovision | each | EUR 8346 |
PDGF-AA, human recombinant |
|||
4482-50 | Biovision | each | EUR 1123.2 |
PDGF-AB, human recombinant |
|||
4485-10 | Biovision | each | EUR 398.4 |
PDGF-AB, human recombinant |
|||
4485-1000 | Biovision | each | EUR 8346 |
PDGF-AB, human recombinant |
|||
4485-50 | Biovision | each | EUR 1123.2 |
Anti-angiogenic results of crenolanib are mediated by mitotic modulation independently of PDGFR expression
Crenolanib is a tyrosine kinase inhibitor concentrating on PDGFR-α, PDGFR-β and Fms associated tyrosine kinase-3 (FLT3) that’s presently evaluated in a number of medical trials.
- The exercise of crenolanib on cell viability, migration, sprouting, apoptosis and mitosis was assessed in endothelial cells, tumour cells and fibroblasts. Alterations in cell morphology have been decided by immunofluorescence experiments.
- Movement-cytometry evaluation and mRNA expression profiles have been used to research cell differentiation. In vivo efficacy was investigated in human ovarian carcinoma implanted on the rooster chorioallantoic membrane (CAM).
- Crenolanib was discovered to inhibit endothelial cell viability, migration and sprout size, and induced apoptosis independently of PDGFR expression.
- Handled cells confirmed altered actin association and nuclear aberrations. Mitosis was affected at a number of ranges together with mitosis entry and centrosome clustering. Crenolanib suppressed human ovarian carcinoma tumour progress and angiogenesis within the CAM mannequin.
- The PDGFR/FLT3 inhibitor crenolanib targets angiogenesis and inhibits tumour progress in vivo unrelated to PDGFR expression. Based mostly on our findings, we propose a broad mechanism of motion of crenolanib.
The expression of Platelet-derived Development issue receptors (PDGFRs) and their correlation with total survival of sufferers with ovarian most cancers.
The primary purpose of the research was to research the expression of Platelet-Derived Development Issue Receptors alpha (PDGFR-alpha) and beta (PDGFR-beta) in malignant and benign ovarian tumors. We carried out an evaluation of the correlation of PDGFRs expression and stage of the illness, tumor grade and histopathological sort of epithelial ovarian most cancers (EOC). Moreover, we evaluated affected person prognosis in keeping with PDGFR expression.
anti-PDGF Receptor beta |
Our research group was composed of 52 samples of EOCs, 35 samples of benign ovarian tumors (BOTs), and 21 samples of unchanged ovaries (UOs). The samples have been collected from sufferers who had been operated on within the Division of Gynecological Surgical procedure of the Poznan College of Medical Sciences.
PDGFR-alpha was discovered to be expressed extra regularly in most cancers cells of EOCs, compared with tumor cells of BOTs and epithelium of UOs. Then again, PDGFR-alpha receptors have been current much less regularly within the stroma of EOCs, compared with the stroma of BOTs and UOs.
Evaluating the studied teams, there have been no statistically vital variations within the expression of PDGFR-beta. The expression of each PDGFRs was not associated to the FIGO stage, grade or histopathological sort of EOCs.
The expression of the PDGFR-beta receptor in most cancers cells was related to an improved total survival amongst sufferers with EOCs. Affected person prognosis was not affected by both PDGFR-alpha expression or by PDGFR-beta tumor stroma expression.
The expression of PDGFR-alpha is considerably totally different when evaluating EOCs, BOTs and UOs. Nonetheless, the prognosis of EOC solely appears to be affected by PDGFR-beta expression in most cancers cells.
Human Platelet Derived Growth Factor-BB Recombinant |
|||
MBS553042-0002mg | MyBiosource | 0.002mg | EUR 165 |
Human Platelet Derived Growth Factor-BB Recombinant |
|||
MBS553042-001mg | MyBiosource | 0.01mg | EUR 245 |
Recombinant Human Platelet Derived Growth Factor-BB |
|||
MBS142377-0002mg | MyBiosource | 0.002mg | EUR 240 |
Recombinant Human Platelet Derived Growth Factor-BB |
|||
MBS142377-001mg | MyBiosource | 0.01mg | EUR 310 |
Recombinant Human Platelet Derived Growth Factor-BB |
|||
MBS142377-1mg | MyBiosource | 1mg | EUR 3685 |
Recombinant Human Platelet Derived Growth Factor-BB |
|||
MBS142377-5x1mg | MyBiosource | 5x1mg | EUR 16255 |
Human Platelet Derived Growth Factor BB ELISA kit |
|||
E01A6849 | BlueGene | 96T | EUR 700 |
Description: ELISA |
Human Platelet Derived Growth Factor Bb ELISA Kit |
|||
MBS038698-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 6725 |
Human Platelet Derived Growth Factor Bb ELISA Kit |
|||
MBS038698-48StripWells | MyBiosource | 48-Strip-Wells | EUR 550 |
Human Platelet Derived Growth Factor Bb ELISA Kit |
|||
MBS038698-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 3420 |
Human Platelet Derived Growth Factor Bb ELISA Kit |
|||
MBS038698-96StripWells | MyBiosource | 96-Strip-Wells | EUR 765 |
Human Platelet Derived Growth Factor BB ELISA kit |
|||
E01P0043-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Human Platelet Derived Growth Factor BB in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Platelet Derived Growth Factor BB ELISA kit |
|||
E01P0043-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Human Platelet Derived Growth Factor BB in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Platelet Derived Growth Factor BB ELISA kit |
|||
E01P0043-48wellsplate | BlueGene | 48 wells plate | EUR 280 |
Human Platelet Derived Growth Factor BB ELISA kit |
|||
E01P0043-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Human Platelet Derived Growth Factor BB in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Platelet Derived Growth Factor BB ELISA kit |
|||
E01P0043-96wellsplate | BlueGene | 96 wells plate | EUR 405 |
Human Platelet Derived Growth Factor BB ELISA Kit |
|||
IHUPDGFBBKT | Innovative research | each | EUR 573 |
Description: Human Platelet Derived Growth Factor BB ELISA Kit |
Human Platelet Derived Growth Factor BB ELISA Kit |
|||
MBS721615-48StripWellsCompetitive | MyBiosource | 48-Strip-Wells-(Competitive) | EUR 485 |
Human Platelet Derived Growth Factor BB ELISA Kit |
|||
MBS721615-48StripWellsSandwich | MyBiosource | 48-Strip-Wells-(Sandwich) | EUR 485 |
Human Platelet Derived Growth Factor BB ELISA Kit |
|||
MBS721615-5x96StripWellsCompetitive | MyBiosource | 5x96-Strip-Wells-(Competitive) | EUR 3020 |
Human Platelet Derived Growth Factor BB ELISA Kit |
|||
MBS721615-96StripWellsCompetitive | MyBiosource | 96-Strip-Wells-(Competitive) | EUR 690 |
Human Platelet Derived Growth Factor BB ELISA Kit |
|||
MBS721615-96StripWellsSandwich | MyBiosource | 96-Strip-Wells-(Sandwich) | EUR 690 |
Human Platelet Derived Growth Factor BB (PDGF BB) ELISA Kit |
|||
EKU06685-48T | Biomatik Corporation | 48T | EUR 500.5 |
Human Platelet Derived Growth Factor BB (PDGF BB) ELISA Kit |
|||
EKU06685-5x96T | Biomatik Corporation | 5x96T | EUR 3396.25 |
Human Platelet Derived Growth Factor BB (PDGF BB) ELISA Kit |
|||
EKU06685-96T | Biomatik Corporation | 96T | EUR 715 |
Human Platelet Derived Growth Factor BB (PDGF BB) ELISA Kit |
|||
EKN47796-48T | Biomatik Corporation | 48T | EUR 341.04 |
Human Platelet Derived Growth Factor BB (PDGF BB) ELISA Kit |
|||
EKN47796-5x96T | Biomatik Corporation | 5x96T | EUR 2314.2 |
Human Platelet Derived Growth Factor BB (PDGF BB) ELISA Kit |
|||
EKN47796-96T | Biomatik Corporation | 96T | EUR 487.2 |
Human Platelet Derived Growth Factor-BB CLIA Kit |
|||
MBS8425806-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Platelet Derived Growth Factor-BB (PDGF-BB) |
|||
GWB-F9EF47 | GenWay Biotech | 0.01 mg | Ask for price |
Human Platelet Derived Growth Factor-BB ELISA Kit |
|||
MBS761215-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 3900 |
Human Platelet Derived Growth Factor-BB ELISA Kit |
|||
MBS761215-48StripWells | MyBiosource | 48-Strip-Wells | EUR 340 |
Human Platelet Derived Growth Factor-BB ELISA Kit |
|||
MBS761215-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 2045 |
Human Platelet Derived Growth Factor-BB ELISA Kit |
|||
MBS761215-96StripWells | MyBiosource | 96-Strip-Wells | EUR 455 |
Platelet Derived Growth Factor BB, Recombinant, Human (PDGF-BB) |
|||
MBS650362-001mg | MyBiosource | 0.01mg | EUR 420 |
Platelet Derived Growth Factor BB, Recombinant, Human (PDGF-BB) |
|||
MBS650362-5x001mg | MyBiosource | 5x0.01mg | EUR 1730 |
Platelet Derived Growth Factor BB, Recombinant, Human (PDGF-BB) |
|||
MBS650366-0002mg | MyBiosource | 0.002mg | EUR 340 |
Platelet Derived Growth Factor BB, Recombinant, Human (PDGF-BB) |
|||
MBS650366-001mg | MyBiosource | 0.01mg | EUR 490 |
Platelet Derived Growth Factor BB, Recombinant, Human (PDGF-BB) |
|||
MBS650366-5x001mg | MyBiosource | 5x0.01mg | EUR 2055 |
Platelet Derived Growth Factor BB, Recombinant, Human (PDGF-BB) |
|||
MBS650457-0002mg | MyBiosource | 0.002mg | EUR 340 |
Platelet Derived Growth Factor BB, Recombinant, Human (PDGF-BB) |
|||
MBS650457-001mg | MyBiosource | 0.01mg | EUR 490 |
Platelet Derived Growth Factor BB, Recombinant, Human (PDGF-BB) |
|||
MBS650457-5x001mg | MyBiosource | 5x0.01mg | EUR 2055 |
Platelet Derived Growth Factor BB, Recombinant, Human (PDGF-BB) |
|||
MBS650980-001mg | MyBiosource | 0.01mg | EUR 595 |
Platelet Derived Growth Factor BB, Recombinant, Human (PDGF-BB) |
|||
MBS650980-5x001mg | MyBiosource | 5x0.01mg | EUR 2535 |
Human Platelet Derived Growth Factor-BB (PDGF-BB) CLIA Kit |
|||
abx197499-96tests | Abbexa | 96 tests | EUR 990 |
Human PDGF-BB (Platelet Derived Growth Factor BB) ELISA Kit |
|||
EKE60948-5x96T | Biomatik Corporation | 5x96T | EUR 3124.08 |
Human PDGF-BB (Platelet Derived Growth Factor BB) ELISA Kit |
|||
EKE60948-96T | Biomatik Corporation | 96T | EUR 657.7 |
Human PDGF-BB(Platelet Derived Growth Factor BB) ELISA Kit |
|||
SYP-H0355-48wellsplate | UpingBio | 48 wells plate | EUR 180 |
Human PDGF-BB(Platelet Derived Growth Factor BB) ELISA Kit |
|||
SYP-H0355-96wellsplate | UpingBio | 96 wells plate | EUR 220 |
Human PDGF-BB(Platelet Derived Growth Factor BB) ELISA Kit |
|||
RE3064H-48wells | Reed Biotech | 48 wells | EUR 125.55 |
Human PDGF-BB(Platelet Derived Growth Factor BB) ELISA Kit |
|||
RE3064H-48wellsplate | Reed Biotech | 48 wells plate | EUR 126 |
Human PDGF-BB(Platelet Derived Growth Factor BB) ELISA Kit |
|||
RE3064H-96wells | Reed Biotech | 96 wells | EUR 179.55 |
Human PDGF-BB(Platelet Derived Growth Factor BB) ELISA Kit |
|||
RE3064H-96wellsplate | Reed Biotech | 96 wells plate | EUR 180 |
Human Platelet Derived Growth Factor BB (PDGFBB) Protein |
|||
abx166431-100g | Abbexa | 100 µg | EUR 487.5 |
Human Platelet Derived Growth Factor BB (PDGFBB) Protein |
|||
20-abx166431 | Abbexa |
|
|
Human Platelet Derived Growth Factor BB (PDGFBB) Protein |
|||
abx166431-10g | Abbexa | 10 µg | EUR 200 |
Human Platelet Derived Growth Factor BB (PDGFBB) Protein |
|||
abx166431-50g | Abbexa | 50 µg | EUR 350 |
Human PDGF-BB -Platelet Derived Growth Factor-BB- CLIA Kit |
|||
E-CL-H1012-24Tests | Elabscience Biotech | 24 Tests | EUR 180 |
Description: Sandwich |
Human PDGF-BB -Platelet Derived Growth Factor-BB- CLIA Kit |
|||
E-CL-H1012-48Tests | Elabscience Biotech | 48 Tests | EUR 546 |
Description: Sandwich |
Human PDGF-BB -Platelet Derived Growth Factor-BB- CLIA Kit |
|||
E-CL-H1012-96Tests | Elabscience Biotech | 96 Tests | EUR 682 |
Description: Sandwich |
Human PDGF-BB -Platelet Derived Growth Factor-BB- CLIA Kit |
|||
E-CL-H1012-96Tests10 | Elabscience Biotech | 96 Tests *10 | EUR 6820 |
Description: Sandwich |
Human PDGF-BB -Platelet Derived Growth Factor-BB- CLIA Kit |
|||
E-CL-H1012-96Tests5 | Elabscience Biotech | 96 Tests *5 | EUR 3410 |
Description: Sandwich |
Human PDGF-BB (Platelet Derived Growth Factor-BB) CLIA Kit |
|||
MBS2533230-5x96Tests | MyBiosource | 5x96Tests | EUR 2565 |
Human PDGF-BB (Platelet Derived Growth Factor-BB) CLIA Kit |
|||
MBS2533230-96Tests | MyBiosource | 96Tests | EUR 560 |
Human PDGF-BB(Platelet Derived Growth Factor-BB) ELISA Kit |
|||
EKF57097-48T | Biomatik Corporation | 48T | EUR 396.9 |
Human PDGF-BB(Platelet Derived Growth Factor-BB) ELISA Kit |
|||
EKF57097-5x96T | Biomatik Corporation | 5x96T | EUR 2693.25 |
Human PDGF-BB(Platelet Derived Growth Factor-BB) ELISA Kit |
|||
EKF57097-96T | Biomatik Corporation | 96T | EUR 567 |
Human PDGF-BB(Platelet Derived Growth Factor-BB) ELISA Kit |
|||
EH0254 | FN Test | 96T | EUR 628.92 |
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 18.75pg/ml |
Human PDGF-BB (Platelet Derived Growth Factor-BB) ELISA Kit |
|||
MBS2505502-10x96Tests | MyBiosource | 10x96Tests | EUR 4060 |
Human PDGF-BB (Platelet Derived Growth Factor-BB) ELISA Kit |
|||
MBS2505502-24Tests | MyBiosource | 24Tests | EUR 265 |
Human PDGF-BB (Platelet Derived Growth Factor-BB) ELISA Kit |
|||
MBS2505502-48Tests | MyBiosource | 48Tests | EUR 450 |
Human PDGF-BB (Platelet Derived Growth Factor-BB) ELISA Kit |
|||
MBS2505502-5x96Tests | MyBiosource | 5x96Tests | EUR 2265 |
Human PDGF-BB (Platelet Derived Growth Factor-BB) ELISA Kit |
|||
MBS2505502-96Tests | MyBiosource | 96Tests | EUR 535 |
Platelet Derived Growth Factor BB (PDGF-BB) (AP) |
|||
MBS6493778-01mL | MyBiosource | 0.1mL | EUR 635 |